(Q34427742)

2 August 2017

1 reference

title

Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible (English)

1 reference

2 August 2017

0 references

1 reference

1

Kvien TK

1 reference

2 August 2017

Uhlig T

2

1 reference

2 August 2017

Kristiansen IS

series ordinal

3

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

61

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

1711-1720

1 reference

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

2 August 2017

cites work

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

12 December 2020

Functional impairment and disability in early rheumatoid arthritis--development over 5 years

1 reference

12 December 2020

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis

1 reference

12 December 2020

Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study

1 reference

12 December 2020

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

12 December 2020

Outcome in rheumatoid arthritis. A 1985 inception cohort study.

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage

1 reference

12 December 2020

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

12 December 2020

The prevalence and severity of rheumatoid arthritis in Oslo. Results from a county register and a population survey.

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study

1 reference

12 December 2020

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

12 December 2020

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

1 reference

12 December 2020

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group

1 reference

12 December 2020

Access to disease modifying treatments for rheumatoid arthritis patients

1 reference

12 December 2020

What is the natural history of rheumatoid arthritis?

1 reference

12 December 2020

The validity of self-reported diagnosis of rheumatoid arthritis: results from a population survey followed by clinical examinations.

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate

1 reference

12 December 2020

The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

12 December 2020

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

12 December 2020

Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis

1 reference

12 December 2020

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)

1 reference

12 December 2020

Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts

1 reference

12 December 2020

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

12 December 2020

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis: not yet curable with early intensive therapy

1 reference

12 December 2020

More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability

1 reference

12 December 2020

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

1 reference

12 December 2020

Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis

1 reference

12 December 2020

The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway.

1 reference

12 December 2020

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

12 December 2020

What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols?

1 reference

12 December 2020

DC-ART classification: review of relevant clinical studies

1 reference

12 December 2020

10.2165/00003495-200161120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1001783285

0 references

1 reference